Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA for Treatment of Idiopathic and Neurogenic Overactive Bladder: a Randomized Trial

NCT04020510 is registered in ClinicalTrials.gov with Walter Reed National Military Medical Center as lead sponsor.

NCT NCT04020510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04020510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA for Treatment of Idiopathic and Neurogenic Overactive Bladder: a Randomized Trial
Lead sponsor
Walter Reed National Military Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
July 1, 2019
Completion date
December 31, 2021
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder